Capsocam Colon
Payments companies reported to CMS as associated with Capsocam Colon. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Capsocam Colon, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Capsocam Colon
These are the largest totals companies reported as associated with Capsocam Colon. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mike Wei | Stanford, CA | Gastroenterology (Internal Medicine) | $334,085.82 |
| Margaret Zhou | Stanford, CA | Gastroenterology (Internal Medicine) | $241,600.84 |
| Andrew Li | Stanford, CA | Gastroenterology (Internal Medicine) | $200,598.33 |
| Shai Friedland | Stanford, CA | Gastroenterology (Internal Medicine) | $177,350.83 |
| Suejin Kim | San Jose, CA | Gastroenterology (Internal Medicine) | $143,475.44 |
| Ngozi Enwerem | Dallas, TX | $126,398.25 | |
| David Shields | Palo Alto, CA | Gastroenterology (Internal Medicine) | $121,437.50 |
| Wassem Juakiem | Biloxi, MS | Gastroenterology (Internal Medicine) | $107,258.70 |
| Mayurathan Kesavan | Doylestown, PA | Gastroenterology (Internal Medicine) | $107,125.00 |
| Walter Park | Stanford, CA | Gastroenterology (Internal Medicine) | $94,467.49 |
Prescribed Capsocam Colon?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.